Roadmap or Roadkill: A Pharmacologist’s Analysis of the NIH Molecular Libraries Initiative

Table 2.

Roadmap Research: Grants in Neurobiology

Grant Title Grant Type Principal Investigator
Development of a high throughput screening Galanin 3 receptor assay R21 Steven J. Brown, Scripps
A cell-based screen for inhibitors of intracellular Abeta aggregation R21 Matthew P. Delisa, Cornell
Chemical probes for uncovering differential regulators of apoptosis in cells R03 Monanish Deshmukh, UNC
HTS technology for discovery of drugs targeting GPCR oligomers R21 Pyare L. Khanna, DiscoveRx Corporation
A cell-based screen for small molecule binders of mutant huntingtin messenger RNA R21 Robert E. Hughes, Buck Institute for Age Research
Inhibitor screens for five MAPK kinase kinases important in human disease R21 Gary L. Johnson, UNC
Assay development to identifiy palmitoylation inhibitors of neuronal proteins R21 Maurine E. Linder, Washington U
Multiplexed flow cytometry screens for RGS inhibitors R21 Richard R. Neubig, University of Michigan
High-throughput screening assay development for axonopathic neurodegeration R21 Norbert Perrimon, Harvard
Assay development relating to the HTS of the neuropeptide Y-Y2 receptor R21 Claes Wahlestedt, Scripps
Discovery of novel allosteric modulators of the M1 muscarinic receptor XO1 P. Jeffrey Conn, Vanderbilt
Ligands for premortem diagnosis and treatment of Alzheimer’s disease XO1 Jeff A. Kuret, Ohio State
Discovery of novel allosteric agonist of the M4 muscarinic receptor XO1 Colleen M. Niswender, Vanderbilt
EphA4 receptor antagonists for nervous system repair XO1 Elena B. Pasquale, Burnham Institute
Allosteric modulators of D1 receptors XO1 Val J. Watts, Purdue

This Article

  1. MI October 2006 vol. 6 no. 5 240-243